Latest debt-to-equity ratio
Keros Therapeutics Debt-to-equity ratio
Direct answer
Keros Therapeutics's debt-to-equity ratio is 5.99%.
The verified market snapshot reports 5.99%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.99%
Explore related company data
View Keros Therapeutics's market capitalizationView Keros Therapeutics's price-to-book ratioView Keros Therapeutics's return on equityView Keros Therapeutics's dividend yieldView Keros Therapeutics's 52-week price rangeView Keros Therapeutics's profit marginView all Keros Therapeutics key metricsReturn to Keros Therapeutics profile